A New At-home Telerehabilitation Care Service Delivery Model for Stroke Survivors in the Rio Grande Valley

March 12, 2026 updated by: Fadi Musfee, The University of Texas Health Science Center, Houston
The purpose of this study is to investigate the feasibility of a mobile telerehabilitation software for post-acute stroke care for Rio Grande Valley (RGV) stroke survivors with community health worker (CHW) at-home support and to estimate the functional health, mental health (depression), and caregiver burden outcomes of this new CHW-supported, at-home rehabilitation service delivery model and to identify salient barriers to and facilitators of adopting and delivering the new rehabilitation delivery model to further disseminate the model in real-world communities.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • The University of Texas Health Science Center at Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • A resident of the Brownsville, Texas (Cameron County) area
  • SINGLE and FIRST qualifying stroke event with the ability to enroll and begin study activities within 3 months of onset of stroke event
  • Pre-stroke modified Rankin score of ≤3 (less than moderate disability at baseline)
  • Currently uninsured
  • Spanish or English speaker
  • Able to follow instructions (without aphasia that interferes with following instructions)
  • Safe to perform basic strengthening rehabilitation exercises
  • Able to stand with or without assistance

Exclusion Criteria:

  • Aphasia or cognitive impairment (e.g., dementia) that interferes with following instructions or prevents following the study-related activities)
  • Pre-stroke motor deficits
  • Current psychiatric disorders, including substance use disorder
  • Underlying brain pathologies inclusive of brain malignancies, multiple sclerosis
  • Insured patients as insured patients are referred for standard-of-care clinical rehabilitation.
  • Medical instability to participate in basic strengthening rehabilitation exercises
  • Inability to access internet from home to access at-home rehabilitation software for intervention arm participants
  • Having received any outpatient rehabilitation services prior to study enrollment for intervention arm participants

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CHW-supported telerehabilitation plus Usual Care
Participants will receive the Mobile Rehab mobile software, which allows participants to be prescribed personalized rehabilitation strengthening video regimens electronically based on respondent-indicated mobility and activities of daily living functionality
Participants will be provide a list of local social services resources, including mental health, that participants can use . A callback number will be provided if they have any questions about the services.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in basic mobility as assessed by the Acute Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Form (routine)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
This is an 18 item questionnaire and each is scored from 1(unable) to 4( none) for a score range of 1-72, higher score indicating better outcome
Baseline (week 1), week 3 (intervention participants only), week 6
Change in basic mobility as assessed by the Acute Measure for Post-Acute Care (AM-PAC) Basic Mobility Outpatient Form (low function )
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
This is a 19 item questionnaire and each is scored from 0(unable) to 3( none) for a score range of 0-57, higher score indicating better outcome
Baseline (week 1), week 3 (intervention participants only), week 6
Change in basic activity as Acute Measure for Post-Acute Care (AM-PAC) Daily Activity Outpatient Short Form (routine)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
This is a 15 item questionnaire and each is scored from 1(unable) to 4( none) for a score range of 1-60, higher score indicating better outcome
Baseline (week 1), week 3 (intervention participants only), week 6
Change in basic activity as Acute Measure for Post-Acute Care (AM-PAC) Daily Activity Outpatient Short Form (low function)
Time Frame: Baseline (week 1), week 3 (intervention participants only), week 6
This is a 12 item questionnaire and each is scored from 0(total) to 3( none) for a score range of 1-36, higher score indicating better outcome
Baseline (week 1), week 3 (intervention participants only), week 6
Change in Health-related quality of life as assessed by the European Health-Related Quality of Life- 5 Dimensions (EQ-5D) EuroQoL-5D five-level survey (EQ-5D-5L)
Time Frame: Baseline, week 3 (intervention participants only), week 6
This is scored across 5 dimensions , mobility, self-care, usual activities, pain/discomfort, and anxiety/depression and each dimension is scored on a five-level severity ranking that ranges from 1 (no problems) to 5 (extreme problems), higher score indicating worse outcome
Baseline, week 3 (intervention participants only), week 6
Change in Depression as assessed by the Patient Health Questionnaire 9 (PHQ-9)
Time Frame: Baseline, week 3 (intervention participants only), week 6
This is a 9 item questionnaire and each is scored from 0(not at all) to 3(nearly every day) for a score range of 0-27, higher score indicating worse outcome
Baseline, week 3 (intervention participants only), week 6
Change in caregiver burden as assessed by the Zarit Burden Interview
Time Frame: Baseline, week 3 (intervention participants only), week 6
This is a 12 item questionnaire and each is scored from 0(never) to 4(nearly always) for a score range of 0-48, higher score indicating worse outcome
Baseline, week 3 (intervention participants only), week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability/Appropriateness of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: Baseline
This is an 8 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-40, higher score indicating better outcome
Baseline
Acceptability/Appropriateness of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: week 7
This is an 8 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-40, higher score indicating better outcome
week 7
Adoption of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: Baseline
This is an 5 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-25, higher score indicating better outcome
Baseline
Adoption of the intervention for the stroke survivors as assessed by the Quantitative Implementation Measures for Stroke Survivors questionnaire
Time Frame: week 7
This is an 5 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-25, higher score indicating better outcome
week 7
Acceptability & Appropriateness of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
Baseline
Acceptability & Appropriateness of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
week 7
Adoption of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
This is an 4 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-20, higher score indicating better outcome
Baseline
Adoption of the intervention for the community health workers as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7
This is an 4 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-20, higher score indicating better outcome
week 7
Feasibility of Community Health Worker as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: Baseline
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
Baseline
Feasibility of Community Health Worker as assessed by the Quantitative Implementation Measures for Community Health Worker questionnaire
Time Frame: week 7 (immediately after intervention)
This is an 7 item questionnaire and each is scored from 1( strongly disagree) to 5(strongly agree) for a score range of 1-35, higher score indicating better outcome
week 7 (immediately after intervention)
Feasibility as assessed by the number of participants enrolled
Time Frame: end of study (week 7)
end of study (week 7)
Adherence as assessed by the number of rehab videos watched in a day
Time Frame: end of study (week 7)
adherence is defined by ≥1 daily mobile rehab video usage
end of study (week 7)
Number of participants that view ≥1 daily mobile rehab videos
Time Frame: end of study (week 7)
end of study (week 7)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fadi Musfee, MD, The University of Texas Health Science Center, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 17, 2025

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

August 29, 2024

First Submitted That Met QC Criteria

August 29, 2024

First Posted (Actual)

August 30, 2024

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 12, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on CHW-supported telerehabilitation

Subscribe